Teladoc Health Target of Unusually Large Options Trading (NYSE:TDOC)

Teladoc Health, Inc. (NYSE:TDOC) was the recipient of unusually large options trading on Thursday. Stock traders acquired 61,931 call options on the company. This represents an increase of 377% compared to the typical volume of 12,988 call options.

Insiders Place Their Bets

In related news, Director Thomas Mckinley purchased 4,000 shares of the company’s stock in a transaction dated Thursday, September 12th. The shares were acquired at an average cost of $7.69 per share, with a total value of $30,760.00. Following the completion of the purchase, the director now owns 39,077 shares of the company’s stock, valued at $300,502.13. The trade was a 11.40 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Michael Willem Waters sold 4,218 shares of the firm’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total transaction of $30,200.88. Following the transaction, the chief operating officer now directly owns 78,309 shares in the company, valued at approximately $560,692.44. The trade was a 5.11 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 20,051 shares of company stock worth $143,565 over the last ninety days. Company insiders own 0.95% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. TCW Group Inc. bought a new position in Teladoc Health in the 3rd quarter worth about $2,464,000. Geode Capital Management LLC boosted its position in Teladoc Health by 1.5% during the 3rd quarter. Geode Capital Management LLC now owns 3,925,167 shares of the health services provider’s stock worth $36,042,000 after acquiring an additional 56,864 shares during the period. Y Intercept Hong Kong Ltd acquired a new position in shares of Teladoc Health in the 3rd quarter valued at about $152,000. Quantinno Capital Management LP boosted its holdings in shares of Teladoc Health by 190.4% during the third quarter. Quantinno Capital Management LP now owns 186,143 shares of the health services provider’s stock worth $1,709,000 after purchasing an additional 122,050 shares during the period. Finally, Point72 Asset Management L.P. grew its position in Teladoc Health by 57.8% during the third quarter. Point72 Asset Management L.P. now owns 8,366,295 shares of the health services provider’s stock valued at $76,803,000 after purchasing an additional 3,063,172 shares in the last quarter. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the company. Piper Sandler decreased their target price on Teladoc Health from $25.00 to $10.00 and set an “overweight” rating on the stock in a report on Tuesday, August 6th. Needham & Company LLC reissued a “hold” rating on shares of Teladoc Health in a research note on Thursday, August 1st. Canaccord Genuity Group cut their price target on Teladoc Health from $25.00 to $17.00 and set a “buy” rating on the stock in a research note on Thursday, August 1st. Deutsche Bank Aktiengesellschaft increased their price target on Teladoc Health from $10.00 to $12.00 and gave the stock a “hold” rating in a report on Friday, November 1st. Finally, JPMorgan Chase & Co. reduced their price target on shares of Teladoc Health from $16.00 to $9.00 and set a “neutral” rating for the company in a research report on Monday, August 26th. Fourteen research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $12.08.

Teladoc Health Stock Up 15.1 %

Teladoc Health stock traded up $1.36 during trading on Thursday, reaching $10.36. The stock had a trading volume of 5,857,042 shares, compared to its average volume of 5,513,731. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The business has a 50 day moving average price of $9.00 and a 200 day moving average price of $9.31. The stock has a market cap of $1.78 billion, a PE ratio of -1.66 and a beta of 0.90. Teladoc Health has a 52-week low of $6.76 and a 52-week high of $22.54.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.10. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The firm had revenue of $640.51 million for the quarter, compared to analyst estimates of $630.50 million. On average, analysts predict that Teladoc Health will post -1.17 EPS for the current year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.